{"id":4025,"date":"2023-07-15T14:10:41","date_gmt":"2023-07-15T14:10:41","guid":{"rendered":"https:\/\/wapcpharm.org\/journal\/?p=4025"},"modified":"2023-07-15T14:25:53","modified_gmt":"2023-07-15T14:25:53","slug":"west-african-journal-of-pharmacy-2021-32-1-1-11","status":"publish","type":"post","link":"https:\/\/wapcpharm.org\/journal\/west-african-journal-of-pharmacy-2021-32-1-1-11\/","title":{"rendered":"West African Journal of Pharmacy (2021) 32 (1) 1 – 11"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Protective measures against COVID-19 and provision of pharmaceutical services in Nigerian hospitals<\/b><\/p>

\u00a0<\/b><\/p>

Wilson O. Erhun , Ochuko M. Orherhe , Kingsley C. Amibor<\/span><\/p>

\u00a0<\/p>

1Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy,<\/p>

Obafemi Awolowo University, P.M.B. 13, Ile-Ife, Osun State, Nigeria.<\/p>

2Deputy Director of Pharmaceutical Services (DDPS), Federal Medical Centre, Asaba,\u00a0Delta State, Nigeria.<\/span><\/p>

\u00a0<\/p>

Corresponding Author: Ochuko M. Orherhe<\/p>

Email: oorherhe@oauife.edu.ng; Phone: +2348051589453<\/p>

Running Title: Protective measures against COVID-19<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

ABSTRACT<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Background:<\/strong> The World Health Organization has specified guidelines for healthcare workers when providing healthcare services in the bid to curb the spread of COVID-19.<\/p>

Objectives:<\/strong> The study aimed at evaluating the level of adherence to protective measures against COVID-19 in the provision of pharmaceutical services in Nigerian hospitals.<\/p>

Methods:<\/strong> A cross-sectional self-administered structured questionnaire based survey of 109 hospital pharmacists across 55 hospitals in Nigeria between April and May 2020. Data was summarized with frequencies and percentages and Chi-square was used to compare categorical variables at p<0.05.<\/p>

Results:<\/strong> Majority of the respondents; 92 (84.4%), reported that they had direct contact with patients when conversing and 54 (49.5%) of them complained that the challenge of maintaining physical distancing impeded their effectiveness. Physical distancing was sub-optimal in about three- quarter; 78 (72.5%), of the pharmacy waiting area of the facilities studied. About one-third of the respondents; 43 (39.6%), reported optimal standards of other protective measures in their pharmacies. Non-tertiary level hospitals had better protective measures in 2 their patient waiting area than the tertiary level hospitals ( = 5.586, p = 0.018), but the practice setting did not 2 affect protective measures in the pharmacy ( = 2.022, p = 0.155).<\/p>

Conclusion:<\/strong> Majority of the hospital pharmacists did not adhere to protective measures against COVID-19 in the provision of pharmaceutical services in Nigerian hospitals.<\/p>

Keywords:<\/strong> COVID-19; Protective measures; Pharmaceutical services; Physical distancing<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\tDownload <\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Protective measures against COVID-19 and provision of pharmaceutical services in Nigerian hospitals \u00a0 Wilson O. Erhun , Ochuko M. Orherhe , Kingsley C. Amibor \u00a0 1Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy, Obafemi Awolowo University, P.M.B. 13, Ile-Ife, Osun State, Nigeria. 2Deputy Director of Pharmaceutical Services (DDPS), Federal Medical Centre, Asaba,\u00a0Delta State, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[229],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4025"}],"collection":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/comments?post=4025"}],"version-history":[{"count":7,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4025\/revisions"}],"predecessor-version":[{"id":4041,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4025\/revisions\/4041"}],"wp:attachment":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/media?parent=4025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/categories?post=4025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/tags?post=4025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}